Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis-Reference-Cited by-同舟云学术

Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis

Published:2022-11 Issue:11 Volume:4 Page:100544
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Schramm Christoph^ORCID,Wedemeyer Heiner,Mason Andrew^ORCID,Hirschfield Gideon M.,Levy Cynthia^ORCID,Kowdley Kris V.,Milkiewicz Piotr,Janczewska Ewa^ORCID,Malova Elena Sergeevna,Sanni Johanne,Koo Phillip,Chen Jin,Choudhury Subhajit,Klickstein Lloyd B.,Badman Michael K.,Jones David

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference36 articles.

1. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis;J Hepatol,2017

2. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review;Boonstra;J Hepatol,2012

3. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines;Hirschfield;Gut,2018

4. Primary biliary cholangitis: 2018 Practice guidance from the American Association for the Study of Liver Diseases;Lindor;Hepatology,2019

5. Primary biliary cirrhosis;Carey;Lancet,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The gut microbiota-bile acid axis in cholestatic liver disease;Molecular Medicine;2024-07-19

2. Role of FXR in the development of NAFLD and intervention strategies of small molecules;Archives of Biochemistry and Biophysics;2024-07

3. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

4. Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid;European Journal of Internal Medicine;2024-06

5. Investigational farnesoid X receptor agonists for the treatment of primary biliary cholangitis;Expert Opinion on Investigational Drugs;2024-05-07